Phase I/II Study of Metastatic Melanoma Patients Treated with Nivolumab Who Had Progressed after Ipilimumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase I/II Study of Metastatic Melanoma Patients Treated with Nivolumab Who Had Progressed after Ipilimumab

Published:2016-02-12 Issue:4 Volume:4 Page:345-353
ISSN:2326-6066
Container-title:Cancer Immunology Research
language:en
Short-container-title:Cancer Immunol Res

Author:

Weber Jeffrey,Gibney Geoffrey,Kudchadkar Ragini,Yu Bin,Cheng Pingyan,Martinez Alberto J.,Kroeger Jodie,Richards Allison,McCormick Lori,Moberg Valerie,Cronin Heather,Zhao Xiuhua,Schell Michael,Chen Yian Ann

Funder

National Cancer Institute

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Immunology

Cited by 215 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Aging and Senescence in Immune Checkpoint Inhibitor Response and Toxicity;International Journal of Molecular Sciences;2024-06-27

2. RNAi mediated silencing of STAT3/PD-L1 in tumor-associated immune cells induces robust anti-tumor effects in immunotherapy resistant tumors;Molecular Therapy;2024-06

3. Nivolumab and Ipilimumab Acting as Tormentors of Advanced Tumors by Unleashing Immune Cells and Associated Collateral Damage;Pharmaceutics;2024-05-29

4. Myeloid-derived suppressor cells in peripheral blood as predictive biomarkers in patients with solid tumors undergoing immune checkpoint therapy: systematic review and meta-analysis;Frontiers in Immunology;2024-05-24

5. Immune Regulation and Immune Therapy in Melanoma: Review with Emphasis on CD155 Signalling;Cancers;2024-05-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP